Reviews describe BPC-157 as a synthetic pentadecapeptide derived from gastric protein research and investigated across a wide range of preclinical models
Borasio GD, Robberecht W, Leigh PN, et al
Subcutaneous Injection Protocol Injections are delivered with a small insulin-size needle into the subcutaneous fat, typically the abdomen or thigh
At no point does PGG Wrightson has access to, or store any of your credit or debit card information
Together, these findings and the wide range of effectiveness of the BPC 157 regimens (pg, ng, g, eye drops, or systemically, including via per-oral route) (for review see [1,2,3,4,5,6,7,8,9,10,96,97,106,107,193]) may be suggestive of further BPC 157 therapy application
Introduction BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide first isolated from gastric juice